Pharmaceutical composition and the process for its preparation
   
   

The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thia zolidine-2,4-dione as active ingredient.

A invenção atual fornece uma composição pharmaceutical estável nova que contem 5-[[4-[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thia zolidine-2,4-dione como o ingrediente ativo.
 
Web www.patentalert.com

< VZV ORF29p protein-related compositions and methods

< Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof

> Methods for coating pharmaceutical core tablets

> Compositions and methods for drug delivery using pH sensitive molecules
~ 00106